ERBB2 and breast carcinoma: Interestingly, inducing GRP78 overexpressing in the human basal (i.e. ER-/PR-/Her2-) breast cancer cell line MDA-MB-231 caused an increased resistance to the chemotherapeutic drug cisplatin (Fig. 2G).